Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
- Autori: Todaro, M.; Orlando, V.; Cicero, G.; Caccamo, N.R.; Meraviglia, S.; Stassi, G.; Dieli, F.
- Anno di pubblicazione: 2013
- Tipologia: Articolo in rivista (Articolo in rivista)
- OA Link: http://hdl.handle.net/10447/100602
Abstract
According to common beliefs, conventional anticancer chemotherapy is deleterious for the immune system. We have recently provided in vitro evidence indicating that conventional chemotherapy may potentiate, rather than impair, the long-term efficacy of γδ T cell-based anticancer immunotherapy. © 2013 Landes Bioscience.